These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

853 related articles for article (PubMed ID: 19913598)

  • 21. Postmenopausal hormone therapy and cognition.
    McCarrey AC; Resnick SM
    Horm Behav; 2015 Aug; 74():167-72. PubMed ID: 25935728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on.
    Maki PM; Henderson VW
    Climacteric; 2012 Jun; 15(3):256-62. PubMed ID: 22612612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The menopause and HRT. HRT and cognitive decline.
    Maki P; Hogervorst E
    Best Pract Res Clin Endocrinol Metab; 2003 Mar; 17(1):105-22. PubMed ID: 12763515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alzheimer's disease, dementia, mild cognitive impairment and the menopause: a 'window of opportunity'?
    Davey DA
    Womens Health (Lond); 2013 May; 9(3):279-90. PubMed ID: 23638783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex steroids to maintain cognitive function in women after the menopause: a meta-analyses of treatment trials.
    Hogervorst E; Bandelow S
    Maturitas; 2010 May; 66(1):56-71. PubMed ID: 20202765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of combination estrogen plus progestin hormone treatment on cognition and affect.
    Resnick SM; Maki PM; Rapp SR; Espeland MA; Brunner R; Coker LH; Granek IA; Hogan P; Ockene JK; Shumaker SA;
    J Clin Endocrinol Metab; 2006 May; 91(5):1802-10. PubMed ID: 16522699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Future therapeutic developments of estrogen use.
    Fillit H
    J Clin Pharmacol; 1995 Sep; 35(9S):25S-28S. PubMed ID: 8530715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of Alzheimer's disease, cerebrovascular disease and dementia in women: the case for menopause hormone therapy.
    Davey DA
    Neurodegener Dis Manag; 2017 Feb; 7(1):85-94. PubMed ID: 28074678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postmenopausal hormone therapy: new questions and the case for new clinical trials.
    Manson JE; Bassuk SS; Harman SM; Brinton EA; Cedars MI; Lobo R; Merriam GR; Miller VM; Naftolin F; Santoro N
    Menopause; 2006; 13(1):139-47. PubMed ID: 16607110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What we know about estrogen's effect on the brain.
    Mitchell JL
    Curr Womens Health Rep; 2002 Oct; 2(5):382-9. PubMed ID: 12215311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homocysteine, estrogen and cognitive decline.
    Shah S; Bell RJ; Davis SR
    Climacteric; 2006 Apr; 9(2):77-87. PubMed ID: 16698655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alzheimer's disease, apolipoprotein E and hormone replacement therapy.
    Depypere H; Vierin A; Weyers S; Sieben A
    Maturitas; 2016 Dec; 94():98-105. PubMed ID: 27823753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term consequences of estrogens administered in midlife on female cognitive aging.
    Daniel JM; Witty CF; Rodgers SP
    Horm Behav; 2015 Aug; 74():77-85. PubMed ID: 25917862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis.
    Hogervorst E; Williams J; Budge M; Riedel W; Jolles J
    Neuroscience; 2000; 101(3):485-512. PubMed ID: 11113299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.
    Rossouw JE; Prentice RL; Manson JE; Wu L; Barad D; Barnabei VM; Ko M; LaCroix AZ; Margolis KL; Stefanick ML
    JAMA; 2007 Apr; 297(13):1465-77. PubMed ID: 17405972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen: a neuroprotective or proinflammatory hormone? Emerging evidence from reproductive aging models.
    Sohrabji F
    Ann N Y Acad Sci; 2005 Jun; 1052():75-90. PubMed ID: 16024752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review.
    Sherwin BB; Henry JF
    Front Neuroendocrinol; 2008 Jan; 29(1):88-113. PubMed ID: 17980408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic features of menopausal and postmenopausal applicants for life insurance.
    Schiefeling M
    J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormone replacement therapy for cognitive function in postmenopausal women.
    Lethaby A; Hogervorst E; Richards M; Yesufu A; Yaffe K
    Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD003122. PubMed ID: 18254016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A systematic review of clinical trials of hormone therapy on cognitive function: effects of age at initiation and progestin use.
    Maki PM
    Ann N Y Acad Sci; 2005 Jun; 1052():182-97. PubMed ID: 16024761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.